Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 21584335)

1.

Challenge of studies on the development of new Zn complexes (Zn(opt)₂) to treat diabetes mellitus.

Yoshikawa Y, Murayama A, Adachi Y, Sakurai H, Yasui H.

Metallomics. 2011 Jul;3(7):686-92. doi: 10.1039/c1mt00014d. Epub 2011 May 17.

PMID:
21584335
2.

A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.

Adachi Y, Yoshida J, Kodera Y, Kato A, Yoshikawa Y, Kojima Y, Sakurai H.

J Biol Inorg Chem. 2004 Oct;9(7):885-93. Epub 2004 Sep 18.

PMID:
15378407
4.

A new type of orally active anti-diabetic Zn(II)-dithiocarbamate complex.

Yoshikawa Y, Adachi Y, Sakurai H.

Life Sci. 2007 Jan 30;80(8):759-66. Epub 2006 Nov 10.

PMID:
17137606
6.

Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S(2)O(2)) coordination mode.

Takeshita S, Kawamura I, Yasuno T, Kimura C, Yamamoto T, Seki J, Tamura A, Sakurai H, Goto T.

J Inorg Biochem. 2001 Jun;85(2-3):179-86.

PMID:
11410238
7.

[Challenge of studies on the development of new Zn complexes to treat diabetes mellitus].

Yoshikawa Y, Sakurai H, Yasui H.

Yakugaku Zasshi. 2011;131(6):925-30. Review. Japanese.

8.

Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies.

Yoshikawa Y, Ueda E, Kawabe K, Miyake H, Takino T, Sakurai H, Kojima Y.

J Biol Inorg Chem. 2002 Jan;7(1-2):68-73. Epub 2001 Jul 11.

PMID:
11862542
9.

A family of insulinomimetic zinc(II) complexes of amino ligands with Zn(Nn) (n=3 and 4) coordination modes.

Yoshikawa Y, Kondo M, Sakurai H, Kojima Y.

J Inorg Biochem. 2005 Jul;99(7):1497-503.

PMID:
15921760
10.

Insulinomimetic Zn complex (Zn(opt)2) enhances insulin signaling pathway in 3T3-L1 adipocytes.

Basuki W, Hiromura M, Sakurai H.

J Inorg Biochem. 2007 Apr;101(4):692-9. Epub 2007 Jan 17.

PMID:
17316811
11.

Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.

Yamaguchi M, Wakasugi K, Saito R, Adachi Y, Yoshikawa Y, Sakurai H, Katoh A.

J Inorg Biochem. 2006 Feb;100(2):260-9. Epub 2006 Jan 4.

PMID:
16387366
12.
14.

Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.

Buglyó P, Crans DC, Nagy EM, Lindo RL, Yang L, Smee JJ, Jin W, Chi LH, Godzala Iii ME, Willsky GR.

Inorg Chem. 2005 Jul 25;44(15):5416-27.

PMID:
16022540
15.
16.

The pharmacology of the insulinomimetic effect of zinc complexes.

Sakurai H, Adachi Y.

Biometals. 2005 Aug;18(4):319-23. Review.

PMID:
16158223
17.

Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus.

Yoshikawa Y, Ueda E, Miyake H, Sakurai H, Kojima Y.

Biochem Biophys Res Commun. 2001 Mar;281(5):1190-3.

PMID:
11243860
18.

Development of a novel antidiabetic zinc complex with an organoselenium ligand at the lowest dosage in KK-A(y) mice.

Fujimoto S, Yasui H, Yoshikawa Y.

J Inorg Biochem. 2013 Apr;121:10-5. doi: 10.1016/j.jinorgbio.2012.12.008. Epub 2012 Dec 23.

PMID:
23314593
19.
20.

The action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytes.

Yoshikawa Y, Ueda E, Kojima Y, Sakurai H.

Life Sci. 2004 Jun 25;75(6):741-51.

PMID:
15172182
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk